Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsOseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory commentsNeuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisSafety and efficacy of peramivir for influenza treatmentOseltamivir prescription and regulatory actions vis-à-vis abnormal behavior risk in Japan: drug utilization study using a nationwide pharmacy databaseThe Tamiflu fiasco and lessons learntThe pharmacological management of severe influenza infection - 'existing and emerging therapies'.Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.2009 H1N1 influenza.Use of oseltamivir in childrenPredispensing of antivirals to high-risk individuals in an influenza pandemicPre-dispensing of antivirals to high-risk individuals in an influenza pandemic.Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.Pandemic influenza A (H1N1) 2009 with neurological manifestations, a case series.Antivirals for influenza: strategies for use in pediatrics.Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.Safety profile of oseltamivir during the 2009 influenza pandemic.Parkinson's disease or Parkinson symptoms following seasonal influenza.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.Sedation and analgesia usage in severe pandemic H1N1 (2009) infection: a comparison to respiratory failure secondary to other infectious pneumonias.Recent advances in the diagnosis and treatment of influenza pneumonia.The national pandemic flu service, oseltamivir, and a case of pancreatitis.Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.The neuropsychiatric aspects of influenza/swine flu: A selective review.Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance.Evaluation of [(11)C]oseltamivir uptake into the brain during immune activation by systemic polyinosine-polycytidylic acid injection: a quantitative PET study using juvenile monkey models of viral infectionGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theThe use of antiviral drugs for influenza: Guidance for practitioners 2012/2013Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients.Oseltamivir (tamiflu) induced depressive episode in a female adolescent.In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties.The mechanisms of sudden-onset type adverse reactions to oseltamivir.Health care personnel and risk of H1N1-chemoprophylaxis with oseltamivir.Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivirPopulation pharmacokinetics of oseltamivir: pediatrics through geriatrics.Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.
P2860
Q21090775-A698EAF5-D103-4869-A6D0-AACD45ED76A0Q24240097-7F6D218D-1291-4414-B34C-721F94F910B8Q24244898-CEA485AE-F82F-498A-B92D-EA1AEDBB9E22Q24568345-C5FA42EC-1EF9-4F2E-947E-7D615B1B8A4AQ24644585-52423BAB-6ABB-41B7-9DD4-3C2BB7BF0318Q27027408-C79B25CB-836E-4A92-86B2-E135230036D3Q28478300-FF7BEBD9-5455-42B6-8B3D-CBE1B0D57272Q28545064-40138109-2FBE-4530-B80A-1B4AC2D4150DQ30243907-B36771BC-E17E-4349-AFA0-EF757F763A54Q30382944-00C1E32A-6E49-47F9-B090-C7A57C3A6E6AQ30383437-1EA8381B-3F62-4806-8F6A-CEBF64095CC4Q30383447-99C9D1C8-2953-478D-B8E8-8D477D952C5EQ30383781-5829F23E-E9A5-40D2-912D-A086DE326365Q30385808-99CC3A03-37FC-4FFD-89C9-995731709A88Q30386485-9278BDCD-805E-4768-868E-D859FCB81695Q30388366-E1B82AF8-0382-4999-99EA-1C05BA4C6010Q30393095-75FD6A41-B638-473C-B194-57AF21C9456EQ30394541-3EFAED45-3F0F-4E0A-84AE-B756C4CBBE33Q30401279-E2B2D7A8-61F5-4A9D-B25C-228E2C39A75FQ30403795-89038574-FEF5-4D6E-8847-8E9B4645DBA3Q30409023-FD79A6D4-A54E-4A54-A6E3-FC2200D7A6D0Q30410665-8A3E4F35-542C-4809-8ED9-7EE2537AE78CQ30415002-0F773296-A029-4FB7-A024-168C931BB269Q30415146-33A3F219-797F-4507-8A1F-491B80B4C447Q30423248-5D0F025C-C066-41B5-91BC-2853F67A2447Q30425173-3CF81329-63F5-4A8B-AFC6-C116C9F8FC5AQ33162322-31D15E94-E50C-41F5-AA3C-519E803006F1Q33909405-5B298B98-38EA-4F5E-9966-EBDB35A14B7FQ34212799-88CAFD16-2061-4418-934D-1A40DFE1E2F6Q34389114-66FDD725-E725-4451-80C1-FB3CF092EF2DQ34457416-8ED454C9-FEB8-40AE-80C7-1E6ABED468FCQ34497585-29844A13-BFCA-4833-8C87-B372CA1380D8Q34576146-EC7A95C7-BC21-49E0-941A-CEE4CC0172F7Q34677701-85E2C5F6-CCAC-4E9D-945D-637ADAEAE42BQ36470220-2A908108-B305-40EB-9D49-7705E7C55243Q36593645-FC1EB95D-2E07-46E3-ABD8-3327CAAA4BFBQ36783997-5F9DA971-17C3-4D34-980D-0BF7F8C64C49Q37036527-0F11F699-E048-4451-A43D-21B7495CD01CQ37348462-9DC77780-8CD6-4174-B174-422DC7B3673CQ37409972-9E0F5B7C-6F2F-442F-8303-72E9F5EDE94D
P2860
Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of neuropsychiatric ...... mivir: a comprehensive review.
@en
Assessment of neuropsychiatric ...... mivir: a comprehensive review.
@nl
type
label
Assessment of neuropsychiatric ...... mivir: a comprehensive review.
@en
Assessment of neuropsychiatric ...... mivir: a comprehensive review.
@nl
prefLabel
Assessment of neuropsychiatric ...... mivir: a comprehensive review.
@en
Assessment of neuropsychiatric ...... mivir: a comprehensive review.
@nl
P2093
P2860
P1433
P1476
Assessment of neuropsychiatric ...... mivir: a comprehensive review.
@en
P2093
Alexander Breidenbach
Barbara Donner
Bharat Thakrar
Craig Rayner
David Reddy
Ellen Carey
Eric Prinssen
Gerhard Hoffmann
Jonathan Solsky
P2860
P304
P356
10.2165/0002018-200831120-00006
P577
2008-01-01T00:00:00Z
P6179
1002394351